Immunotherapy responsive malignancy

Systemic Anti-Cancer Therapy (SACT) guidance including pathways for managing complications and adverse events directly linked to SACT which may present both in emergency departments and on the general wards. This covers both chemotherapy and immune related toxicities.

Immunostimulants
Immunosuppressants - Malignancy

On Formulary Preferred
On Formulary Second Line
On Formulary Third Line

Specialist Initiation
Secondary Care Only
Not Approved for Formulary